| Dr Mildred Murphy Clifton, MD | |
|
901 Se Plaza Ave, Ste 5, Bentonville, AR 72712-5697 | |
| (479) 273-3376 | |
| (479) 273-3468 |
| Full Name | Dr Mildred Murphy Clifton |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 25 Years |
| Location | 901 Se Plaza Ave, Bentonville, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679521405 | NPI | - | NPPES |
| 04D1034086 | Other | AR | CLIA |
| 150037001 | Medicaid | AR | |
| 155059002 | Medicaid | AR | |
| 5M432 | Other | AR | BCBS # |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Premier Dermatology Pllc | 4082926803 | 14 |
News Archive
The recent ruling in the Sottera, Inc. v. Food & Drug Administration case has once again brought the E-Cigarette industry into the spotlight and Green Nicotine Electronic Cigarettes could not be better prepared. Many electronic cigarette companies will have to scramble to prepare for FDA regulation, but Green Nicotine Electronic Cigarettes has been prepared for these types of regulations since 2009.
Government and health care services are being urged to make special help available for young people who inject drugs, in a bid to minimize drug-related deaths.
The Canadian Pharmacists Association (CPhA) urges the federal government to enhance its national immunization strategy to ensure that all Canadians have the opportunity to protect themselves against the common strains of HPV (human papillomavirus) through immunization.
Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for priority review Eisai's New Drug Application (NDA) for AcipHex Delayed-Release Sprinkle Capsules 5mg and 10mg for the proposed indication of healing of Gastroesophageal Reflux Disease (GERD), maintenance of healing of GERD and improvement of symptoms of GERD in children 1 to 11 years of age.
A study published in The Journal of the American Medical Association (JAMA) reveals that an increasing number of vascular risk factors such as obesity, high blood pressure, diabetes, high cholesterol, and smoking during midlife contributes to increased brain amyloid levels (protein fragments associated with Alzhemier's, the most common form of dementia) in later life.
› Verified 8 days ago
| Entity Name | Premier Dermatology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386022283 PECOS PAC ID: 4082926803 Enrollment ID: O20150708001957 |
News Archive
The recent ruling in the Sottera, Inc. v. Food & Drug Administration case has once again brought the E-Cigarette industry into the spotlight and Green Nicotine Electronic Cigarettes could not be better prepared. Many electronic cigarette companies will have to scramble to prepare for FDA regulation, but Green Nicotine Electronic Cigarettes has been prepared for these types of regulations since 2009.
Government and health care services are being urged to make special help available for young people who inject drugs, in a bid to minimize drug-related deaths.
The Canadian Pharmacists Association (CPhA) urges the federal government to enhance its national immunization strategy to ensure that all Canadians have the opportunity to protect themselves against the common strains of HPV (human papillomavirus) through immunization.
Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for priority review Eisai's New Drug Application (NDA) for AcipHex Delayed-Release Sprinkle Capsules 5mg and 10mg for the proposed indication of healing of Gastroesophageal Reflux Disease (GERD), maintenance of healing of GERD and improvement of symptoms of GERD in children 1 to 11 years of age.
A study published in The Journal of the American Medical Association (JAMA) reveals that an increasing number of vascular risk factors such as obesity, high blood pressure, diabetes, high cholesterol, and smoking during midlife contributes to increased brain amyloid levels (protein fragments associated with Alzhemier's, the most common form of dementia) in later life.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mildred Murphy Clifton, MD 901 Se Plaza Ave, Ste 5, Bentonville, AR 72712-5697 Ph: (479) 273-3376 | Dr Mildred Murphy Clifton, MD 901 Se Plaza Ave, Ste 5, Bentonville, AR 72712-5697 Ph: (479) 273-3376 |
News Archive
The recent ruling in the Sottera, Inc. v. Food & Drug Administration case has once again brought the E-Cigarette industry into the spotlight and Green Nicotine Electronic Cigarettes could not be better prepared. Many electronic cigarette companies will have to scramble to prepare for FDA regulation, but Green Nicotine Electronic Cigarettes has been prepared for these types of regulations since 2009.
Government and health care services are being urged to make special help available for young people who inject drugs, in a bid to minimize drug-related deaths.
The Canadian Pharmacists Association (CPhA) urges the federal government to enhance its national immunization strategy to ensure that all Canadians have the opportunity to protect themselves against the common strains of HPV (human papillomavirus) through immunization.
Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for priority review Eisai's New Drug Application (NDA) for AcipHex Delayed-Release Sprinkle Capsules 5mg and 10mg for the proposed indication of healing of Gastroesophageal Reflux Disease (GERD), maintenance of healing of GERD and improvement of symptoms of GERD in children 1 to 11 years of age.
A study published in The Journal of the American Medical Association (JAMA) reveals that an increasing number of vascular risk factors such as obesity, high blood pressure, diabetes, high cholesterol, and smoking during midlife contributes to increased brain amyloid levels (protein fragments associated with Alzhemier's, the most common form of dementia) in later life.
› Verified 8 days ago
Kattie J Allen, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 901 Se Plaza Ave, Suite 5, Bentonville, AR 72712 Phone: 479-273-3376 Fax: 479-273-3468 | |
Dr. Eric Eugene Belin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 901 Se Plaza Ave Ste 5, Bentonville, AR 72712 Phone: 479-273-3376 | |
Dr. Blake Anthony Williams, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 901 Se Plaza Ave, Suite 5, Bentonville, AR 72712 Phone: 479-273-3376 | |
Cheri Caroline Cunningham, M.D Dermatology Medicare: Accepting Medicare Assignments Practice Location: 901 Se Plaza Ave Ste 5, Bentonville, AR 72712 Phone: 479-273-3376 Fax: 479-273-3468 | |
Laura Raquel Battle, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 901 Se Plaza Ave Ste 5, Bentonville, AR 72712 Phone: 479-254-9662 | |
Dr. Courtney Selck Book, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 901 Se Plaza Ave Ste 5, Bentonville, AR 72712 Phone: 479-273-3376 Fax: 479-273-3468 |